INSR, insulin receptor, 3643

N. diseases: 452; N. variants: 109
Source: ALL
Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
CUI: C0011882
Disease: Diabetic Neuropathies
Diabetic Neuropathies
0.520 AlteredExpression group BEFREE Nonetheless, there are changes in the expression of insulin receptor during the progress of diabetic neuropathy, suggesting that this disorder begins before high glucose blood levels are established. 30742965 2019
CUI: C0011882
Disease: Diabetic Neuropathies
Diabetic Neuropathies
0.520 Biomarker group CTD_human Early changes in insulin receptor signaling and pain sensation in streptozotocin-induced diabetic neuropathy in rats. 18331706 2008
CUI: C0011882
Disease: Diabetic Neuropathies
Diabetic Neuropathies
0.520 Biomarker group BEFREE Here, we created an insulin resistant SC by deleting both insulin receptor (INSR) and insulin-like growth factor receptor 1 (IGF1R), to determine the role of this signaling pathway in development and response to injury in order to understand SC defects in DN. 31758725 2020
CUI: C0011882
Disease: Diabetic Neuropathies
Diabetic Neuropathies
0.520 Biomarker group RGD Early changes in insulin receptor signaling and pain sensation in streptozotocin-induced diabetic neuropathy in rats. 18331706 2008
CUI: C0013146
Disease: Drug abuse
Drug abuse
0.300 Biomarker group CTD_human Genome wide association for addiction: replicated results and comparisons of two analytic approaches. 20098672 2010
CUI: C0013222
Disease: Drug Use Disorders
Drug Use Disorders
0.300 Biomarker group CTD_human Genome wide association for addiction: replicated results and comparisons of two analytic approaches. 20098672 2010
CUI: C0024115
Disease: Lung diseases
Lung diseases
0.300 Biomarker group CTD_human Prenatal administration of retinoic acid upregulates insulin-like growth factor receptors in the nitrofen-induced hypoplastic lung. 21433279 2011
CUI: C0024115
Disease: Lung diseases
Lung diseases
0.300 Biomarker group CTD_human Insulin receptor is downregulated in the nitrofen-induced hypoplastic lung. 20438933 2010
CUI: C0038586
Disease: Substance Use Disorders
Substance Use Disorders
0.300 Biomarker group CTD_human Genome wide association for addiction: replicated results and comparisons of two analytic approaches. 20098672 2010
CUI: C0236969
Disease: Substance-Related Disorders
Substance-Related Disorders
0.300 Biomarker group CTD_human Genome wide association for addiction: replicated results and comparisons of two analytic approaches. 20098672 2010
CUI: C0271680
Disease: Diabetic Polyneuropathies
Diabetic Polyneuropathies
0.300 Biomarker group CTD_human Early changes in insulin receptor signaling and pain sensation in streptozotocin-induced diabetic neuropathy in rats. 18331706 2008
CUI: C1510472
Disease: Drug Dependence
Drug Dependence
0.300 Biomarker group CTD_human Genome wide association for addiction: replicated results and comparisons of two analytic approaches. 20098672 2010
CUI: C0023903
Disease: Liver neoplasms
Liver neoplasms
0.270 AlteredExpression group BEFREE Additionally, we show that plasma levels of cleaved IR reflect IR isoform A expression levels in liver tumors, which prompts us to propose that the measurement of circulating cleaved IR may assist hepatic cancer detection and management. 29610518 2018
CUI: C0023903
Disease: Liver neoplasms
Liver neoplasms
0.270 AlteredExpression group BEFREE Only very high concentrations of insulin-like growth factor I and human proinsulin can compete for the insulin receptor binding and suppress HBsAg production, this suggests that insulin may act through its receptor binding to suppress HBsAg expression in human hepatoma Hep3B cells. 2475498 1989
CUI: C0023903
Disease: Liver neoplasms
Liver neoplasms
0.270 Biomarker group RGD Additionally, we show that plasma levels of cleaved IR reflect IR isoform A expression levels in liver tumors, which prompts us to propose that the measurement of circulating cleaved IR may assist hepatic cancer detection and management. 29610518 2018
CUI: C0023903
Disease: Liver neoplasms
Liver neoplasms
0.270 Biomarker group BEFREE We next studied HTC-IR(Delta485-599) cells, which overexpress a mutant IR with a deletion in the alpha-subunit connecting domain that does not undergo autophosphorylation in response to insulin binding. 11574415 2001
CUI: C0023903
Disease: Liver neoplasms
Liver neoplasms
0.270 AlteredExpression group BEFREE The ability of leptin to augment liver IR activation and PTP1B expression was also observed in vitro in human hepatoma cells (HepG2). 14976221 2004
CUI: C0023903
Disease: Liver neoplasms
Liver neoplasms
0.270 Biomarker group RGD Mitogenic insulin receptor-A is overexpressed in human hepatocellular carcinoma due to EGFR-mediated dysregulation of RNA splicing factors. 23633480 2013
CUI: C0023903
Disease: Liver neoplasms
Liver neoplasms
0.270 AlteredExpression group BEFREE Insulin receptor mRNA levels and insulin binding activity were reduced in HepG2 cultured at lower glucose concentrations. 2543399 1989
CUI: C0023903
Disease: Liver neoplasms
Liver neoplasms
0.270 AlteredExpression group BEFREE Failure to replace complete medium resulted in growth arrest of HepG2 cells and a six- to sevenfold increase in insulin-receptor mRNA due to the prolongation of insulin-receptor mRNA half-life. 1849849 1991
CUI: C0023903
Disease: Liver neoplasms
Liver neoplasms
0.270 GeneticVariation group BEFREE We have now constructed a human insulin receptor mutant in which 3 residues in this sequence were altered (Thr-Cys-Pro-Pro-Pro-Tyr-Tyr-His-Phe-Gln-Asp to Thr-Cys-Pro-Arg-Arg-Tyr-Tyr-Asp-Phe-Gln-Asp) and have expressed this mutant in rat hepatoma (HTC) cells. 2550426 1989
CUI: C0011849
Disease: Diabetes Mellitus
Diabetes Mellitus
0.200 AlteredExpression group BEFREE Importantly, this phenotype was reversible (i.e., discontinuation of Dox treatment led to INSR re-expression and remission of diabetes symptoms). 19017805 2008
CUI: C0011849
Disease: Diabetes Mellitus
Diabetes Mellitus
0.200 GeneticVariation group BEFREE The "T" allele of the His1085His polymorphism in the INSR gene shows significant protection against diabetes. 22775283 2012
CUI: C0011849
Disease: Diabetes Mellitus
Diabetes Mellitus
0.200 Biomarker group BEFREE Rodents with tissue-specific knockout of the insulin receptor in the β-cell (βIRKO) show reduced first-phase glucose-stimulated insulin secretion (GSIS) and with aging develop glucose intolerance and diabetes, phenotypically similar to the process seen in human T2D. 22928576 2012
CUI: C0011849
Disease: Diabetes Mellitus
Diabetes Mellitus
0.200 Biomarker group BEFREE The purpose of this study was to introduce the foreskin as a novel model to examine developmental programming in human neonates, particularly in regard to adipogenesis and insulin receptor signaling, major contributors to age-associated diseases such as obesity and diabetes. 28034763 2017